Cargando…
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Revascularization of Left Main Coronary Artery Disease
Owing to a large-jeopardized myocardium, left main coronary artery disease (LMCAD) represents the substantial high-risk anatomical subset of obstructive coronary artery disease. For several decades, coronary artery bypass grafting (CABG) has been the “gold standard” treatment for LMCAD. Along with a...
Autores principales: | Park, Sangwoo, Park, Seung-Jung, Park, Duk-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011221/ https://www.ncbi.nlm.nih.gov/pubmed/36914602 http://dx.doi.org/10.4070/kcj.2022.0333 |
Ejemplares similares
-
Percutaneous Coronary Intervention for Left Main Coronary Artery Disease: Present Status and Future Perspectives
por: Park, Sangwoo, et al.
Publicado: (2022) -
Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting for the Treatment of Left Main Coronary Artery Disease
por: Cho, Sang-Cheol, et al.
Publicado: (2019) -
Left Main Coronary Artery Revascularization in Patients with Impaired Renal Function: Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting
por: Daoulah, Amin, et al.
Publicado: (2023) -
Conduits’ Biology Regulates the Outcomes of Coronary Artery Bypass Grafting
por: Gharibeh, Lara, et al.
Publicado: (2021) -
Clinical Outcome of Noncardiac Surgery in Patients With History of Coronary Artery Revascularization by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery
por: Park, Jungchan, et al.
Publicado: (2018)